INTERNATIONAL PATENT: ANAVEX LIFE SCIENCES CORP. FILES APPLICATION FOR "BLARCAMESINE CORRECTION OF EEG BIOMARKERS IN FRAGILE X SYNDROME"

GENEVA, Nov. 11 -- ANAVEX LIFE SCIENCES CORP. (630 5th Avenue, 20th FloorNew York, New York 10111) filed a patent application (PCT/US2025/027171) for "BLARCAMESINE CORRECTION OF EEG BIOMARKERS IN FRAGILE X SYNDROME" on Apr 30, 2025. With publication no. WO/2025/231180, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MISSLING, Dr. Christopher U. (630 5th Avenue, 20th FloorNew York, New York 10111)

Abstract: The present disclosure relates to Sigma-1 receptor agonists, and their target engagement and capacity to correct mul...